Using a fluorescent‐tagged gelatin degradation assay, we found that sorted CD133+ liver CSCs in both Huh7 and PLC8024 HCC cell line populations displayed an increased ability to degrade the ECM compared to their CD133− non‐CSC counterparts (Figure 1C). This evidence concerns the gene PROM1 and hepatocellular carcinoma.